Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Akamai (AKAM) downgraded to Neutral from Outperform at Baird with analyst William citing the lack of improving media trends, the lack of a near-term catalyst, and Street estimates that appear to him to be too high. Power lowered his price target to $55 from $60 on Akamai shares. 2. Celgene (CELG) downgraded to Hold from Buy at Argus with analyst David Toung citing valuation, Revlimid revenue concentration risk, and large discounts for Otezla. 3. Estee Lauder (EL) downgraded to Hold from Buy at Societe Generale. 4. Ball Corp. (BLL) downgraded to Hold on limited upside at Vertical Research with analyst Chip Dillon citing limited upside to his new $83 price target, which he raised from $81. 5. TreeHouse (THS) was downgraded to Market Perform from Outperform at Wells Fargo and to Neutral from Outperform at Wedbush. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.